Imperial College London

DrCandiceRoufosse

Faculty of MedicineDepartment of Immunology and Inflammation

Clinical Reader in Renal Pathology
 
 
 
//

Contact

 

+44 (0)20 3313 3280c.roufosse

 
 
//

Location

 

Commonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Chan:2012,
author = {Chan, K and Charif, R and Galliford, J and Goodall, D and Hakim, N and McLean, A and Roufosse, C and Cook, T and Papalois, V and Taube, D},
pages = {314--314},
publisher = {WILEY-BLACKWELL},
title = {Induction with Alemtuzumab Should Be Weight Adjusted To Achieve Optimal Outcomes in Renal Transplant Recipients.},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000303235502202&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2012}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Chan,K
AU - Charif,R
AU - Galliford,J
AU - Goodall,D
AU - Hakim,N
AU - McLean,A
AU - Roufosse,C
AU - Cook,T
AU - Papalois,V
AU - Taube,D
EP - 314
PB - WILEY-BLACKWELL
PY - 2012///
SN - 1600-6135
SP - 314
TI - Induction with Alemtuzumab Should Be Weight Adjusted To Achieve Optimal Outcomes in Renal Transplant Recipients.
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000303235502202&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -